about
Dengue, chikungunya and Zika and mass gatherings: What happened in Brazil, 2014Chikungunya virus infectionChikungunya fever: a clinical and virological investigation of outpatients on Reunion Island, South-West Indian OceanPersisting Mixed Cryoglobulinemia in Chikungunya InfectionThe challenge of chronic chikungunyaDelayed focal lipoatrophy after AS03-adjuvanted influenza A (H1N1) 2009 vaccine.Adverse events following pandemic influenza vaccine Pandemrix® reported in the French military forces--2009-2010.Antimalarial drug use in general populations of tropical Africa.The challenge of diagnosing Plasmodium ovale malaria in travellers: report of six clustered cases in French soldiers returning from West Africa.Two Cases of Leptospirosis in French Travelers Returning From Koh Samui, Thailand.Illness in French travelers to Senegal: prospective cohort follow-up and sentinel surveillance data.Identification of initial severity determinants to predict arthritis after chikungunya infection in a cohort of French gendarmes.Chikungunya infection: an emerging rheumatism among travelers returned from Indian Ocean islands. Report of 47 cases.Multinormal in vitro distribution model suitable for the distribution of Plasmodium falciparum chemosusceptibility to doxycycline.Specific management of post-chikungunya rheumatic disorders: a retrospective study of 159 cases in Reunion Island from 2006-2012.Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of Plasmodium falciparum.Interventions for treating patients with chikungunya virus infection-related rheumatic and musculoskeletal disorders: A systematic review.Epidemiological and entomological studies of a malaria outbreak among French armed forces deployed at illegal gold mining sites reveal new aspects of the disease's transmission in French GuianaLongitudinal study assessing the return of chloroquine susceptibility of Plasmodium falciparum in isolates from travellers returning from West and Central Africa, 2000-2011Factors associated with malaria chemoprophylaxis compliance among French service members deployed in Central African Republic.Ibuprofen can induce syndrome of inappropriate diuresis in healthy young patients.Travel-associated diseases, Indian Ocean Islands, 1997-2010.Prosthetic joint infection caused by Pasteurella multocida: a case series and review of literature.Failure of dihydroartemisinin plus piperaquine treatment of falciparum malaria by under-dosing in an overweight patient.Chikungunya: a paradigm of emergence and globalization of vector-borne diseases.Imported loiasis in France: a retrospective analysis of 47 cases.Crossing the Gulf of Aden: cutaneous infections in African migrant shipwreck survivors.Epidemiological profile of cutaneous larva migrans in travelers returning to France between 2003 and 2015.An unusual disseminated viral primary infection: rash, hepatitis and polyserositis.Rheumatic manifestations associated with Chikungunya virus infection: A study of 307 patients with 32-month follow-up (RHUMATOCHIK study).Evolution of the prevalence of intestinal parasitic infections among the French armed forces in French Guiana.Travel reported by pilgrims from Marseille, France before and after the 2010 Hajj.Inflammation of the external ear in acute chikungunya infection: Experience from the outbreak in Johor Bahru, Malaysia, 2008.Efficacy of antimalarial chemoprophylaxis for travelers.Leptospirosis in a French traveler returning from Mauritius.Overweight and obesity in French Hajj pilgrims.Imported falciparum malaria in adults: host- and parasite-related factors associated with severity. The French prospective multicenter PALUREA cohort study.Rift Valley fever in kidney transplant recipient returning from Mali with viral RNA detected in semen up to four months from symptom onset, France, autumn 2015.Extended spectrum of antibiotic susceptibility for tuberculosis, djibouti.A new challenge for hospitals in southeast France: monitoring local populations of Aedes albopictus to prevent nosocomial transmission of dengue or chikungunya.
P50
Q22330684-CABA8F6A-CB25-4082-A20B-452AAA6ED266Q24497757-773A4E2B-DE81-4434-B836-6FD35242F22BQ27305283-4AECF883-BEA2-41B7-AC00-5C08A5043FE8Q27487761-7780787C-E8D9-49A7-971F-CD7C8240A1BCQ28804236-F11BE418-4EF0-47F5-815A-19C466D6C930Q30397706-00D7F319-6E0E-4F89-9212-16754B535B76Q30399376-A525EA17-A4A1-4171-9CF9-439446143BD0Q30482961-976FA11B-DCA1-4E41-BC64-44AD41E19F28Q33393204-8B0244D8-344C-4BFE-81E9-FF8DCBADB837Q33426272-9F2E6CA8-2AAE-4EBC-A769-7E1F3EECB89BQ33709598-ECEA9D7F-1A9F-421C-AB32-7443C96ACF12Q34000129-83CB32A6-132E-4A87-AC27-6D7FE99449B9Q34579545-3125A1FB-EBDF-4F6A-9B0B-C20C2DA54AB9Q34601191-CC457EB5-533F-4C4D-99B0-718CD7FC6341Q35168183-1BF0D40B-F635-41D7-A459-F1D485804868Q35834198-32E03025-EC8E-4250-BC41-72D886CDF077Q36400444-1AE91940-F9D5-432C-832B-175808F9F6BEQ36489841-7B986EA6-5179-4283-B422-4ED95CD39FBAQ36643101-304A044B-4B3F-492C-8377-51A5EEFA8165Q36700981-F6E11A97-BB60-4CFB-8F1F-AF88963D1053Q36959975-33759B2F-5329-49D1-951D-3A66CF55B6B5Q37085091-C1518EE2-7E81-45BF-8485-AC3D7BC4A2A7Q37192604-78F4A97D-2156-40C8-8ECD-41B662F12C16Q37267688-48B41073-4909-4318-93B1-2B536AE9CDEBQ37343061-801BB1D2-1BE8-4B03-8E83-B40F3762B1F8Q38137557-451A62D1-6148-46AE-A3A3-D6371A0836B8Q38565131-BCAF18C4-8BD9-49DD-9467-05816CDE0F43Q38721070-4BA56857-4F30-4EDD-8DF9-CE73D6E78F81Q38892577-2DC77ABB-8570-4824-BCBC-21489965EF57Q38917514-E34D6DBC-1AE3-4FD8-B80D-030A3F6AF33EQ38946381-A7C88756-27E6-490B-94B5-E01CF54A6DAFQ39019112-A571FC32-1BE2-45A6-A81A-C8DBCDC256BFQ39102456-9173EB21-5D21-4629-BE9C-3A39317C44B3Q39460932-29E36F32-0ABD-4CDA-9B04-32BFF7A79603Q39464809-E0D134B1-4494-4373-8FC9-BA10FA2D1C56Q39652803-74DC50AE-CB72-4467-8F61-B545B16820B2Q39773957-92BEBEC6-AC49-4954-8516-BBF916E1D5C0Q40106234-2972A0FA-F846-49BF-A184-93B1AE155C83Q40133546-C12E59AE-DADB-46D0-A793-457D2661F63AQ40247248-DDE65AF9-4060-48AC-899B-71C3B621DC20
P50
description
researcher (ORCID 0000-0002-7443-881X)
@en
wetenschapper
@nl
name
Fabrice Simon
@en
Fabrice Simon
@nl
type
label
Fabrice Simon
@en
Fabrice Simon
@nl
prefLabel
Fabrice Simon
@en
Fabrice Simon
@nl
P31
P496
0000-0002-7443-881X